Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Systems Biology | 7 | 2021 | 481 | 1.590 |
Why?
|
| Computational Biology | 13 | 2021 | 3556 | 1.020 |
Why?
|
| Models, Biological | 9 | 2018 | 9439 | 0.980 |
Why?
|
| Drug Repositioning | 4 | 2022 | 244 | 0.940 |
Why?
|
| Protein Interaction Mapping | 7 | 2021 | 619 | 0.890 |
Why?
|
| Abscisic Acid | 6 | 2013 | 42 | 0.780 |
Why?
|
| Nedocromil | 1 | 2019 | 45 | 0.670 |
Why?
|
| Models, Genetic | 7 | 2010 | 3447 | 0.650 |
Why?
|
| Arabidopsis | 5 | 2014 | 464 | 0.610 |
Why?
|
| Budesonide | 1 | 2019 | 163 | 0.610 |
Why?
|
| Haplotypes | 5 | 2007 | 2728 | 0.570 |
Why?
|
| Algorithms | 13 | 2022 | 14061 | 0.570 |
Why?
|
| Plant Growth Regulators | 3 | 2013 | 51 | 0.550 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 11888 | 0.500 |
Why?
|
| Gene Regulatory Networks | 6 | 2021 | 1747 | 0.500 |
Why?
|
| Placebo Effect | 1 | 2019 | 514 | 0.500 |
Why?
|
| Signal Transduction | 15 | 2021 | 23590 | 0.480 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 572 | 0.460 |
Why?
|
| Disease | 3 | 2021 | 674 | 0.460 |
Why?
|
| Plant Leaves | 2 | 2011 | 156 | 0.440 |
Why?
|
| Differential Threshold | 1 | 2013 | 80 | 0.420 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2019 | 797 | 0.390 |
Why?
|
| Programming, Linear | 2 | 2008 | 8 | 0.370 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1788 | 0.370 |
Why?
|
| Computer Simulation | 10 | 2019 | 6251 | 0.350 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3140 | 0.280 |
Why?
|
| Arabidopsis Proteins | 3 | 2014 | 260 | 0.270 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2009 | 394 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2019 | 16040 | 0.250 |
Why?
|
| RNA, Untranslated | 1 | 2009 | 453 | 0.250 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2007 | 446 | 0.240 |
Why?
|
| Gene Expression Profiling | 5 | 2016 | 9521 | 0.220 |
Why?
|
| Oxidation-Reduction | 3 | 2021 | 2215 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3794 | 0.210 |
Why?
|
| Gene Expression Regulation, Plant | 3 | 2013 | 208 | 0.200 |
Why?
|
| Markov Chains | 1 | 2006 | 967 | 0.200 |
Why?
|
| Databases, Protein | 2 | 2018 | 391 | 0.190 |
Why?
|
| Sequence Alignment | 2 | 2005 | 2171 | 0.190 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1743 | 0.190 |
Why?
|
| Nerve Net | 1 | 2013 | 2310 | 0.180 |
Why?
|
| Asthma | 1 | 2019 | 6269 | 0.180 |
Why?
|
| Leukemia, Large Granular Lymphocytic | 2 | 2011 | 24 | 0.170 |
Why?
|
| Coronary Vessels | 2 | 2021 | 3096 | 0.160 |
Why?
|
| Fibrosis | 4 | 2021 | 2068 | 0.160 |
Why?
|
| Tryptophan | 1 | 2021 | 483 | 0.160 |
Why?
|
| Transcription Factors | 4 | 2019 | 12123 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2898 | 0.160 |
Why?
|
| Endophenotypes | 2 | 2021 | 258 | 0.150 |
Why?
|
| Energy Metabolism | 2 | 2021 | 2891 | 0.150 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 742 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 1083 | 0.150 |
Why?
|
| Collagen Type III | 1 | 2018 | 92 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 2 | 2015 | 938 | 0.150 |
Why?
|
| Complement Activation | 1 | 2020 | 430 | 0.150 |
Why?
|
| Metabolome | 2 | 2015 | 1005 | 0.140 |
Why?
|
| Escherichia coli | 1 | 2009 | 4211 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2019 | 994 | 0.130 |
Why?
|
| Drug Interactions | 1 | 2021 | 1416 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 4618 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4109 | 0.130 |
Why?
|
| Protein Binding | 5 | 2021 | 9298 | 0.130 |
Why?
|
| NADP | 1 | 2017 | 227 | 0.130 |
Why?
|
| Drug Discovery | 3 | 2022 | 1063 | 0.130 |
Why?
|
| Cough | 1 | 2019 | 597 | 0.120 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 706 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11506 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2021 | 3089 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1065 | 0.110 |
Why?
|
| Models, Statistical | 2 | 2006 | 5090 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1322 | 0.110 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3584 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7599 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4772 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2021 | 1806 | 0.110 |
Why?
|
| Digestive System Diseases | 1 | 2015 | 151 | 0.110 |
Why?
|
| NAD | 1 | 2017 | 618 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2013 | 103 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2021 | 3159 | 0.100 |
Why?
|
| Pulmonary Artery | 2 | 2018 | 1935 | 0.100 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 841 | 0.100 |
Why?
|
| Mathematical Computing | 1 | 2012 | 143 | 0.100 |
Why?
|
| Proteome | 2 | 2015 | 1898 | 0.100 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 15647 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 1603 | 0.100 |
Why?
|
| Humans | 32 | 2022 | 766011 | 0.100 |
Why?
|
| Calcinosis | 1 | 2020 | 1478 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 1339 | 0.090 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2010 | 94 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2141 | 0.080 |
Why?
|
| Glucose | 1 | 2021 | 4333 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2020 | 4160 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2445 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4526 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2600 | 0.070 |
Why?
|
| Plants | 1 | 2009 | 332 | 0.070 |
Why?
|
| Genome | 1 | 2015 | 1752 | 0.070 |
Why?
|
| Fungal Proteins | 2 | 2008 | 898 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 618 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 490 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 479 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2022 | 4752 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 701 | 0.060 |
Why?
|
| Animals | 8 | 2021 | 168721 | 0.060 |
Why?
|
| Smad3 Protein | 2 | 2018 | 165 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2015 | 1939 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2014 | 3629 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2011 | 1800 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2006 | 386 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2012 | 2719 | 0.060 |
Why?
|
| Mutation | 3 | 2021 | 30187 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3247 | 0.050 |
Why?
|
| Melanoma | 1 | 2022 | 5696 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2009 | 1140 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8062 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2018 | 3785 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20125 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2011 | 2570 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3563 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 6062 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18972 | 0.050 |
Why?
|
| Kynurenine | 1 | 2021 | 142 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 1996 | 0.040 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2021 | 128 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12800 | 0.040 |
Why?
|
| Base Sequence | 1 | 2011 | 12402 | 0.040 |
Why?
|
| Complement Factor B | 1 | 2020 | 56 | 0.040 |
Why?
|
| Genome, Human | 2 | 2021 | 4445 | 0.040 |
Why?
|
| Complement C5 | 1 | 2020 | 99 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5787 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 106 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 10031 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2014 | 7845 | 0.040 |
Why?
|
| Holistic Health | 1 | 2019 | 47 | 0.040 |
Why?
|
| Ouabain | 1 | 2019 | 246 | 0.040 |
Why?
|
| Neoplasms | 2 | 2021 | 22350 | 0.040 |
Why?
|
| Binding Sites | 1 | 2007 | 5999 | 0.040 |
Why?
|
| E2F1 Transcription Factor | 1 | 2018 | 183 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2021 | 491 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 424 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2006 | 2354 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2007 | 5375 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 5990 | 0.040 |
Why?
|
| Carbamazepine | 1 | 2018 | 224 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.040 |
Why?
|
| Phylogeny | 1 | 2005 | 2835 | 0.030 |
Why?
|
| Arginine | 1 | 2021 | 933 | 0.030 |
Why?
|
| Serine | 1 | 2021 | 824 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10731 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2020 | 852 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2017 | 198 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 890 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2011 | 12768 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2017 | 564 | 0.030 |
Why?
|
| Inflammation | 3 | 2020 | 10844 | 0.030 |
Why?
|
| Models, Animal | 1 | 2021 | 2120 | 0.030 |
Why?
|
| Alleles | 1 | 2006 | 6893 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1247 | 0.030 |
Why?
|
| Thrombosis | 2 | 2020 | 2956 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10429 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2018 | 429 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1497 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 1827 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 463 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 23702 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65236 | 0.030 |
Why?
|
| Phenotype | 2 | 2021 | 16707 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 1166 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2011 | 144 | 0.020 |
Why?
|
| Child | 1 | 2019 | 80510 | 0.020 |
Why?
|
| Male | 5 | 2021 | 363808 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15403 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2012 | 358 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2016 | 544 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 948 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2021 | 2464 | 0.020 |
Why?
|
| Histones | 1 | 2021 | 2592 | 0.020 |
Why?
|
| Propensity Score | 1 | 2018 | 1967 | 0.020 |
Why?
|
| Female | 5 | 2021 | 396159 | 0.020 |
Why?
|
| Genes, Plant | 1 | 2010 | 128 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2184 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5190 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2252 | 0.020 |
Why?
|
| Hyperuricemia | 1 | 2011 | 221 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29915 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5304 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7583 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2823 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8103 | 0.020 |
Why?
|
| Yeasts | 1 | 2008 | 278 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1405 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3335 | 0.020 |
Why?
|
| Heart Failure | 2 | 2021 | 11839 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3747 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14445 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10262 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12520 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81786 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22230 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3909 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5746 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1489 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11642 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 223058 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2011 | 8279 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15887 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18289 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 6544 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41652 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10807 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24299 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 171233 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13455 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 13024 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74870 | 0.010 |
Why?
|
Concepts
(215)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_